ArticleDermatology and therapy2025

Optimizing Psoriasis Treatment with Tildrakizumab: Current Evidence and Expert Recommendations for Treatment Individualization in Clinical Practice.

Ricardo Ruiz-Villaverde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.